DTaP vaccine adult - GlaxoSmithKline

Drug Profile

DTaP vaccine adult - GlaxoSmithKline

Alternative Names: 776423; Boostrix; dTpa Booster Vaccine (263855); Refortrix; Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Boostrix) - GSK

Latest Information Update: 26 Sep 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator GlaxoSmithKline
  • Class Bacterial vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Diphtheria; Pertussis; Tetanus

Most Recent Events

  • 03 Sep 2018 GlaxoSmithKline completes a phase III trial in Diphtheria, Pertussis and Tetanus (In adolescents, In children, In the elderly, Prevention, In volunteers, In adults) in Russia (IM) (NCT03311659)
  • 26 Jan 2018 Phase-III clinical trials in Diphtheria, Pertussis and Tetanus (In adolescents, In children, In the elderly, Prevention, In volunteers, In adults) in Russia (IM) (NCT03311659)
  • 17 Oct 2017 GlaxoSmithKline plans a phase III trial in Diphtheria, Pertussis and Tetanus (Healthy volunteers, Prevention, In children, In adolescents, In adults, In the elderly) in Russia (IM) (NCT03311659)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top